PEPtalk | Small Vessels, Big Problems

Cerebral amyloid angiopathy (CAA) is a cerebrovascular condition that begins about 20 years before symptoms appear. Ellis van Etten, a neurologist, researches how CAA works. She will explain the various clinical manifestations, the role of brain clearance and sleep, and how the immune system is involved.

Additionally, she will discuss how iatrogenic CAA can develop years after neurosurgical treatments and will address the impact of CAA on new Alzheimer’s medications. It will become clear that CAA is often detected late, despite its significant impact on the brain.

For more information visit the website